Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

Inclusion Criteria

• •The study population consisted of allergic participants indicated for treatment with hymenoptera venom immunotherapy (Apis mellifera or Vespula spp.) according to standard clinical practice.
• •Participants of both sexes aged 14 years or more.
• •Participants who have not received immunotherapy with hymenoptera venom in the previous 5 years.
• •Participants who have agreed to take part in the study and sign the informed consent form. In the case of minors, the patient's parent or guardian must also sign.